Myth: Tobacco Plants Are Only For Smoking: Difference between revisions
| Line 47: | Line 47: | ||
*"Professor David Craik and Dr Mark Jackson from UQ’s Institute for Molecular Bioscience have demonstrated native wild tobacco, ''Nicotiana benthamiana'', can potentially produce large quantities of drugs, cheaper and more sustainably than industrial manufacturing methods." | *"Professor David Craik and Dr Mark Jackson from UQ’s Institute for Molecular Bioscience have demonstrated native wild tobacco, ''Nicotiana benthamiana'', can potentially produce large quantities of drugs, cheaper and more sustainably than industrial manufacturing methods." | ||
*"The researchers grew the drug T20K, which is currently in phase 1 clinical trials to treat multiple sclerosis (MS), a devastating autoimmune disease that affects the central nervous system...We have shown it is possible to scale up production of cyclotides in plants, providing a platform for growing other medications for pain, cancer or obesity,” Professor Craik said." | *"The researchers grew the drug T20K, which is currently in phase 1 clinical trials to treat multiple sclerosis (MS), a devastating autoimmune disease that affects the central nervous system...We have shown it is possible to scale up production of cyclotides in plants, providing a platform for growing other medications for pain, cancer or obesity,” Professor Craik said." | ||
===2021: [https://www.nationalgeographic.com/science/article/your-next-vaccine-could-be-grown-in-a-tobacco-plant Your next vaccine could be grown in a tobacco plant]=== | |||
*"The COVID-19 pandemic has exposed glaring gaps in the world’s current vaccine production capacities. Conventional vaccine manufacturing is costly and complex. As a result, only a handful of countries have the technology, human resources, and funds to make vaccines; those that are able have faced recurrent challenges of contamination and quality control in the race to manufacture and distribute billions of COVID-19 vaccines. Conventional vaccines also have to be kept cold, some as cold as -76 degrees Fahrenheit, during transport and storage. The vaccine cold chain is not only costly but is also a major barrier for vaccine distribution in rural, hard-to-reach communities and in countries with limited infrastructure. The solution, some scientists believe, is using plants to manufacture vaccines." | |||
===2020: [https://www.sciencealert.com/large-scale-studies-test-flu-vaccine-derived-from-tobacco-plants-for-the-first-time First-Ever Flu Vaccine Derived From Tobacco Plants Just Smashed Clinical Trials]=== | ===2020: [https://www.sciencealert.com/large-scale-studies-test-flu-vaccine-derived-from-tobacco-plants-for-the-first-time First-Ever Flu Vaccine Derived From Tobacco Plants Just Smashed Clinical Trials]=== | ||